Rehli M - Search Results

1

The IKZF1-IRF4/IRF5 Axis Controls Polarization of Myeloma-Associated Macrophages.

Mougiakakos D, Bach C, Böttcher M, Beier F, Röhner L, Stoll A, Rehli M, Gebhard C, Lischer C, Eberhardt M, Vera J, Büttner-Herold M, Bitterer K, Balzer H, Leffler M, Jitschin S, Hundemer M, Awwad MHS, Busch M, Stenger S, Völkl S, Schütz C, Krönke J, Mackensen A, Bruns H. Mougiakakos D, et al. Among authors: rehli m. Cancer Immunol Res. 2021 Mar;9(3):265-278. doi: 10.1158/2326-6066.CIR-20-0555. Epub 2021 Feb 9. Cancer Immunol Res. 2021. PMID: 33563611

2

High frequency of functionally active Melan-a-specific T cells in a patient with progressive immunoproteasome-deficient melanoma.

Meidenbauer N, Zippelius A, Pittet MJ, Laumer M, Vogl S, Heymann J, Rehli M, Seliger B, Schwarz S, Le Gal FA, Dietrich PY, Andreesen R, Romero P, Mackensen A. Meidenbauer N, et al. Among authors: rehli m. Cancer Res. 2004 Sep 1;64(17):6319-26. doi: 10.1158/0008-5472.CAN-04-1341. Cancer Res. 2004. PMID: 15342421

3

Genome-wide profiling of CpG methylation identifies novel targets of aberrant hypermethylation in myeloid leukemia.

Gebhard C, Schwarzfischer L, Pham TH, Schilling E, Klug M, Andreesen R, Rehli M. Gebhard C, et al. Among authors: rehli m. Cancer Res. 2006 Jun 15;66(12):6118-28. doi: 10.1158/0008-5472.CAN-06-0376. Cancer Res. 2006. PMID: 16778185 Free article.

4

Rapid and sensitive detection of CpG-methylation using methyl-binding (MB)-PCR.

Gebhard C, Schwarzfischer L, Pham TH, Andreesen R, Mackensen A, Rehli M. Gebhard C, et al. Among authors: rehli m. Nucleic Acids Res. 2006 Jul 5;34(11):e82. doi: 10.1093/nar/gkl437. Nucleic Acids Res. 2006. PMID: 16822855 Free PMC article.

5

Characterization of MHC class-I restricted TCRalphabeta+ CD4- CD8- double negative T cells recognizing the gp100 antigen from a melanoma patient after gp100 vaccination.

Voelkl S, Moore TV, Rehli M, Nishimura MI, Mackensen A, Fischer K. Voelkl S, et al. Among authors: rehli m. Cancer Immunol Immunother. 2009 May;58(5):709-18. doi: 10.1007/s00262-008-0593-3. Epub 2008 Oct 3. Cancer Immunol Immunother. 2009. PMID: 18836718 Free PMC article.

6

General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells.

Gebhard C, Benner C, Ehrich M, Schwarzfischer L, Schilling E, Klug M, Dietmaier W, Thiede C, Holler E, Andreesen R, Rehli M. Gebhard C, et al. Among authors: rehli m. Cancer Res. 2010 Feb 15;70(4):1398-407. doi: 10.1158/0008-5472.CAN-09-3406. Epub 2010 Feb 9. Cancer Res. 2010. PMID: 20145141

7

Active DNA demethylation in human postmitotic cells correlates with activating histone modifications, but not transcription levels.

Klug M, Heinz S, Gebhard C, Schwarzfischer L, Krause SW, Andreesen R, Rehli M. Klug M, et al. Among authors: rehli m. Genome Biol. 2010;11(6):R63. doi: 10.1186/gb-2010-11-6-r63. Epub 2010 Jun 18. Genome Biol. 2010. PMID: 20565882 Free PMC article.

8

New aspects of an old drug--diclofenac targets MYC and glucose metabolism in tumor cells.

Gottfried E, Lang SA, Renner K, Bosserhoff A, Gronwald W, Rehli M, Einhell S, Gedig I, Singer K, Seilbeck A, Mackensen A, Grauer O, Hau P, Dettmer K, Andreesen R, Oefner PJ, Kreutz M. Gottfried E, et al. Among authors: rehli m. PLoS One. 2013 Jul 9;8(7):e66987. doi: 10.1371/journal.pone.0066987. Print 2013. PLoS One. 2013. PMID: 23874405 Free PMC article.

9

Identification and characterization of the specific murine NK cell subset supporting graft-versus-leukemia- and reducing graft-versus-host-effects.

Meinhardt K, Kroeger I, Bauer R, Ganss F, Ovsiy I, Rothamer J, Büttner M, Atreya I, Waldner M, Bittrich M, Lehmann CH, Rieger MA, Beilhack A, Zeiser R, Edinger M, Dudziak D, Mackensen A, Rehli M, Ullrich E. Meinhardt K, et al. Among authors: rehli m. Oncoimmunology. 2015 Feb 3;4(1):e981483. doi: 10.4161/2162402X.2014.981483. eCollection 2015 Jan. Oncoimmunology. 2015. PMID: 25949862 Free PMC article.

10

In-vitro blockade of the CD4 receptor co-signal in antigen-specific T-cell stimulation cultures induces the outgrowth of potent CD4 independent T-cell effectors.

Vatter S, Schmid M, Gebhard C, Mirbeth C, Klobuch S, Rehli M, Herr W, Thomas S. Vatter S, et al. Among authors: rehli m. J Immunol Methods. 2018 Mar;454:80-85. doi: 10.1016/j.jim.2017.11.006. Epub 2017 Nov 14. J Immunol Methods. 2018. PMID: 29154771

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

135 results

Search Page